Navigation Links
Single-nucleotide polymorphisms do not substantially improve risk prediction for breast cancer
Date:7/8/2008

Recently identified genetic markers, called single nucleotide polymorphisms (SNPs), that are associated with a small but statistically significant increase in the risk of breast cancer do not appear to substantially improve the accuracy of existing models that use clinical factors to predict an individual's risk, according to a study in the July 8 online issue of the Journal of the National Cancer Institute.

Risk prediction models provide estimates of the risk of disease to assist in clinical management of individual patients. A woman at high risk of breast cancer might benefit from a preventative intervention, whereas the side effects of the intervention might outweigh the benefits in a woman at lower risk of breast cancer. An ideal risk model would provide much higher risk estimates for women who eventually develop breast cancer than for women who do not, a feature called discriminatory accuracy. Researchers have traditionally used clinical information, such as age and family history, to build risk models, but other characteristics can be incorporated into models. Scientists recently identified seven SNPs that are associated with a moderate increase in the risk of breast cancer.

In the current study, Mitchell Gail, M.D., Ph.D., of the National Cancer Institute in Bethesda, Md., compared the discriminatory accuracy of these seven SNPs to an established risk model, called the Breast Cancer Risk Assessment Tool (BCRAT, frequently called the Gail model). BCRAT uses a woman's age, age at menarche and at birth of first child, family history of breast cancer, and breast biopsy results to predict her risk of disease. He also tested whether the addition of the SNPs to the existing model could improve its accuracy.

Gail found that the seven SNPs had less discriminatory accuracy than the BCRAT model. In fact, when he doubled the number of SNPs in the model, by adding seven hypothetical SNPs with similar characteristics, he found that t
'/>"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Alcohol consumption and polymorphisms of cytochromes P4502E1 are high risks for ESCC
2. Spending more for lung cancer treatment did not substantially increase patients lives
3. Myostatin inhibitors may improve recovery of wartime limb injuries
4. Louisiana Improves Law for Treating Mentally Ill
5. Orange County research program aims to improve severe trauma survival rates
6. Ivy Foundation Funds New Brain Cancer Research Consortium : $3M Stage I Project Aims to Improve Personalized Medicine for Patients
7. Pennsylvania Medical Society and AARP Criticize Senator Specter for Blocking Bill to Protect Access to Doctors and Improve Medicare
8. Resveratrol found to improve health, but not longevity in aging mice on standard diet
9. Nanostructures improve bone response to titanium implants
10. Two-Drug Treatment Didnt Improve Cardiac Arrest Survival Rates
11. Indiana State Medical Association and AARP Urge Reconsideration of Bill to Protect Seniors Access to Doctors and Improve Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...epresentatives from the fitness,company Burn Mach... Shriners,Hospitals for Children in Chicago last ...nique, cause; The Burn Machine donated more than $...ent to the first ever Shriners,Wheelchair Bodybui...com/cgi-bin/prnh/20081203/CLW007 ) , "We k...
(Date:12/2/2008)...ersity, The Brigham and Women,s Hospital (Boston),...has found a new drug with the potential to allevia...k. , Dr Shantha Rajaratnam from Monash Universi...gical Medicine said tasimelteon, a drug which acts...ighly effective treatment for circadian rhythm sle...
(Date:12/2/2008)... Reminder, the nation,s leading,comprehensive pat... industry,technology today at Javits Center in Ne...ng and distributing video testimonials can be used... popular platforms such as YouTube, Google,Videos...with an effective,business strategy for increasin...
(Date:12/2/2008)... enterprise software and online services veteran i...scribers of Yugma,s instant web conferencing solut...RWEB) December 2, 2008 -- Yugma , the leading web... collaborate instantly using the Internet, announc...utive Officer. , , ,Vas has more than 20 years of ...
Breaking Medicine News(10 mins):Health News:Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp 2Health News:New medication brings hope of jet lag cure 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3
...onmental Protection announced today that aerial sp...mosquito larvae in Philadelphia have been resched...oLex CG, which is not a chemical pesticide, but is...that targets mosquito and black fly larvae when ad...
...known as integrin alpha 7 (integrin 7) lead to unc...cer, report researchers at the University of Pitt...ed today in the Journal of the National Cancer Ins...a7 represents an important new target for cancer t...
...5N1 strain of bird flu has been detected among pou...n capital, officials said Wednesday. The virus w... Sungai Buloh area of Selangor state, said Kamarud...se control section at the Department of Veterinary...
...to stop feeling hungry, for researchers have devel...rmone which makes people feel full . Researchers d...aturally occurring hormone that is excreted during...he brain called MC4R. When the bodys need for food...
Other Medicine News:Health News:Rescheduled: Aerial Mosquito Treatment for Philadelphia 2Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 2Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 3Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 4Health News:Bird Flu Reappears in Malaysia 2
(Date:11/28/2008)...re/ -- German biotech company,Partec is expanding...ng and,AIDS patient follow-up diagnostics for dev... 2.5 million patient tests have been performed wit...low" system, supporting already,more than 1 milli...n of the,Partec innovation, the average cost of E...
(Date:11/26/2008)...d intelligent clinical applications take workflow ... , CHICAGO, Ill., Nov. 26 /PRNewswire-FirstCall...thcare ) highlights the ACUSON S2000(TM) Automate...rst multi-use, automated volume breast ultrasound ... Meeting of the Radiological Society of North Amer...
(Date:11/25/2008)...nding statin use broadly in wake of AHA-presented ...wswire/ -- JUPITER, a clinical trial suggesting ro...althy patients with elevated CRP, should not promp...to a national poll directed at health professional... poll conducted by medical news site MedPage Today...
(Date:11/25/2008)...ssess Survival of Patients Receiving Litx versus S...ellular Carcinoma , , BELLEVUE, Wash., Nov....(LSO) today announced the completion of enrollment...ion Therapy(TM) (Litx(TM)) as a treatment for unre...n as hepatoma or primary liver cancer. , , ...
Breaking Medicine Technology:German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 1Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 2Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 3Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 4Researchers study facial structures brain abnormalities to reveal formula for detection of autism 4511 1Researchers study facial structures brain abnormalities to reveal formula for detection of autism 4511 2Signals from the Atlantic salmon highway 4508 1Signals from the Atlantic salmon highway 4508 2Signals from the Atlantic salmon highway 4508 3Signals from the Atlantic salmon highway 4508 4Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 1Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 2Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 3Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 4
... the Journal of Clinical Oncology -, NEW YORK, Jul...a,Phase II study - which will be published in the ...ncology (JCO) and are now,available as an Early Re...www.jco.org/">www.jco.org - demonstrate that,ixab...ional,compound, has activity in patients with meta...
... TMC125, an Investigational NNRTI,from Tibotec, YA...m two,ongoing Phase 3 studies (DUET-1 and DUET-2) ...h documented non-nucleoside reverse,transcriptase ...stance reached an undetectable viral load (defined...V-1 RNA copies/mL) with,TMC125 (etravirine), Tibot...
Other Medicine Technology:Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 2Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 3Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 4TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 2TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 3TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 4
The inventory system designed for Wholesale Distributors and centralized distribution centers for Optical chains.
...Ordering/Dispensing has gained recognition as the ... lens ordering system. It enables opticians to pla...g SDS electronic communications technology. When u...r 3D frame tracers, lens shapes are automatically ...
... is a complete practice and business management so...ts, opticians and ophthalmologists- It is designed...ally rich and intuitive windows interface with a f...- The multi-user version of this practice and Busi...
The K-4500 automated hematology analyzer offers fast reliable test results of 18-parameter plus 3-histograms, valuable for effective diagnosis.
Medicine Products: